Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
OX-640 by Orexo for Allergic Rhinitis: Likelihood of Approval
OX-640 is under clinical development by Orexo and currently in Phase I for Allergic Rhinitis. According to GlobalData, Phase I...